Amboss, the Germany-based operator of an online repository for medical research, raised €30m ($32.7m) on Monday from investors including Holtzbrinck Digital, the corporate venturing vehicle for publishing group Holtzbrinck.
Investment firm Partech led the round, participating through its growth fund alongside Target Global, Cherry Ventures and Wellington Partners.
Founded in 2012, Amboss runs an app-based platform where doctors can access the latest medical research in order to make more informed decisions. Medical students can also improve their knowledge through use of its interactive library and exam preparation tools.
The capital will support the company’s expansion into new markets following its entry into the US in 2017, as well as the enhancement of its smart guidance application.
Benedikt Hochkirchen, co-chief executive of Amboss, said: “Our mission is to connect every doctor with precise medical knowledge to provide the best possible care.
“This new funding will allow us to make a meaningful contribution to global health. We are proud of our team’s exceptional achievements and grateful for the trust of our investors. Together, we want to drive the transformation medicine has been waiting for.”
Amboss has not disclosed details about its earlier funding but it had raised an undisclosed amount from Holtzbrinck Digital as of 2016, according to Welt.
